Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Tancini

Showing results (81-90 of 218) with videos related to

Pageof 22
Sort By:
Oncology Reports|May 25, 2011
A clinical-study of immunotherapy versus endocrine therapy versus chemotherapy in the treatment of advanced pancreatic adenocarcinomaP Lissoni, A Ardizzoia, S Meregalli, et al.
The International Journal of Biological Markers|January 1, 1990
Lack of changes in soluble interleukin-2 receptor serum levels during chemotherapy-induced lymphocyte damageC Archili, P Lissoni, G Cattaneo, et al.
Cancer Treatment Reports|June 1, 1987
Synthetic enkephalin analog in the treatment of cancer chemotherapy-induced vomitingP Lissoni, S Barni, S Crispino, et al.
Oncology|September 1, 1995
A biological study on the efficacy of low-dose subcutaneous interleukin-2 plus melatonin in the treatment of cancer-related thrombocytopeniaP Lissoni, S Barni, F Brivio, et al.
Journal of Biological Regulators and Homeostatic Agents|October 1, 1994
Role of the pineal gland in the control of macrophage functions and its possible implication in cancer: a study of interactions between tumor necrosis factor-alpha and the pineal hormone melatoninP Lissoni, S Barni, G Tancini, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 1, 1997
Treatment of cancer chemotherapy-induced toxicity with the pineal hormone melatoninP Lissoni, G Tancini, S Barni, et al.
Tumori|June 30, 1993
Radioendocrine therapy of brain tumors with the long acting opioid antagonist naltrexone in association with radiotherapyP Lissoni, S Meregalli, V Fossati, et al.
American Journal of Surgery|April 1, 1991
Effect of antitumor surgery on soluble interleukin-2 receptor serum levelsF Brivio, P Lissoni, D Mancini, et al.
AJR. American Journal of Roentgenology|September 1, 1976
Laparoscopy and laparotomy in staging Hodgkin's and non-Hodgkin's lymphomaU Veronesi, P Spinelli, G Bonadonna, et al.
The International Journal of Biological Markers|April 1, 1988
Neuroimmunomodulation in cancer patients: correlations between melatonin and beta-endorphin blood levels and T helper/suppressor ratioS Barni, P Lissoni, S Crispino, et al.
Pageof 22

Showing results (81-90 of 218) with videos related to

Sort By:
Pageof 22
Oncology Reports|May 25, 2011
A clinical-study of immunotherapy versus endocrine therapy versus chemotherapy in the treatment of advanced pancreatic adenocarcinomaP Lissoni, A Ardizzoia, S Meregalli, et al.
The International Journal of Biological Markers|January 1, 1990
Lack of changes in soluble interleukin-2 receptor serum levels during chemotherapy-induced lymphocyte damageC Archili, P Lissoni, G Cattaneo, et al.
Cancer Treatment Reports|June 1, 1987
Synthetic enkephalin analog in the treatment of cancer chemotherapy-induced vomitingP Lissoni, S Barni, S Crispino, et al.
Oncology|September 1, 1995
A biological study on the efficacy of low-dose subcutaneous interleukin-2 plus melatonin in the treatment of cancer-related thrombocytopeniaP Lissoni, S Barni, F Brivio, et al.
Journal of Biological Regulators and Homeostatic Agents|October 1, 1994
Role of the pineal gland in the control of macrophage functions and its possible implication in cancer: a study of interactions between tumor necrosis factor-alpha and the pineal hormone melatoninP Lissoni, S Barni, G Tancini, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 1, 1997
Treatment of cancer chemotherapy-induced toxicity with the pineal hormone melatoninP Lissoni, G Tancini, S Barni, et al.
Tumori|June 30, 1993
Radioendocrine therapy of brain tumors with the long acting opioid antagonist naltrexone in association with radiotherapyP Lissoni, S Meregalli, V Fossati, et al.
American Journal of Surgery|April 1, 1991
Effect of antitumor surgery on soluble interleukin-2 receptor serum levelsF Brivio, P Lissoni, D Mancini, et al.
AJR. American Journal of Roentgenology|September 1, 1976
Laparoscopy and laparotomy in staging Hodgkin's and non-Hodgkin's lymphomaU Veronesi, P Spinelli, G Bonadonna, et al.
The International Journal of Biological Markers|April 1, 1988
Neuroimmunomodulation in cancer patients: correlations between melatonin and beta-endorphin blood levels and T helper/suppressor ratioS Barni, P Lissoni, S Crispino, et al.
Pageof 22